Skip to main content

Inside the EU medical device regulation

Despite the MDR going into effect, key parts of the necessary infrastructure are still not fully operational, creating challenges in particular for small- and medium-sized medtech companies. While device makers have resolved some of the near-term pressures, they still face a range of uncertainties and potential problems.

included in this trendline
  • EU MDR costs could cause device shortages for children, medical groups warn
  • MedTech Europe sets out position on cybersecurity, making case for reliance on MDR
  • A regulatory attorney breaks down the EU MDR transition
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.